Last update Sept. 5, 2022
Very Low Risk
Antihistamine drug of 2nd generation, piperidine derivative, which is an active metabolite of Terfenadine, with minimal sedative effect. Oral administration twice a day.
It is excreted into breast milk in clinically non-significant amount. (Lucas 1995)
On a telephone interview, 10% of infants whose mothers were on terfenadine, recognized to have experienced colicky pain and hyperexcitability that disappeared without treatment. (Ito 1993)
Experts authors consider the use of this medication to be safe or very probably safe during breastfeeding (Hale, Briggs 2015, Butler 2014, So 2010, Leachman 2006). American Academy of Pediatrics: medication usually compatible with breastfeeding. (AAP 2001)
Until more published data is known about this drug in relation to breastfeeding, known safer alternatives are preferable, especially during the neonatal period and in the event of prematurity.
Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
e-lactancia is a resource recommended by Asociación Pro Lactancia Materna (APROLAM) of Mexico
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM